ArticleCrohn's & colitis 3602026

Comparative effectiveness and safety of risankizumab vs ustekinumab in patients with Crohn's disease: a propensity score-matched multicenter retrospective cohort study.

Bisher Sawaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.